XML 44 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
The Company (Detail)
3 Months Ended 9 Months Ended
Dec. 31, 2020
USD ($)
Aug. 01, 2018
USD ($)
Sep. 30, 2018
USD ($)
Sep. 30, 2017
USD ($)
Sep. 30, 2018
USD ($)
Segment
Sep. 30, 2017
USD ($)
Jul. 23, 2018
USD ($)
Dec. 31, 2017
USD ($)
Sep. 30, 2014
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Line Items]                  
Number of operating segments | Segment         1        
Research and development expense     $ 28,502,000 $ 12,408,000 $ 59,631,000 $ 33,977,000      
Aggregate amount of senior notes issued               $ 125,000,000  
Induced conversion, expense recognized     24,100,000            
2014 Notes | 2014 Convertible Notes                  
Organization, Consolidation and Presentation of Financial Statements [Line Items]                  
Aggregate amount of senior notes issued               $ 125,000,000 $ 125,000,000
Revolving Credit Facility | Delayed Draw Term Loan                  
Organization, Consolidation and Presentation of Financial Statements [Line Items]                  
Maximum borrowing capacity             $ 100,000,000    
Collaborative Arrangement                  
Organization, Consolidation and Presentation of Financial Statements [Line Items]                  
Amount paid upon execution of collaboration agreement   $ 6,000,000              
Research and development expense     $ 7,400,000            
Collaborative Arrangement | Scenario, Forecast                  
Organization, Consolidation and Presentation of Financial Statements [Line Items]                  
Amount payable on collaborative arrangement $ 9,000,000